{"id":829739,"date":"2025-03-25T17:09:25","date_gmt":"2025-03-25T21:09:25","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\/"},"modified":"2025-03-25T17:09:25","modified_gmt":"2025-03-25T21:09:25","slug":"investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\/","title":{"rendered":"INVESTOR ALERT: Investigation of CorMedix Inc. (CRMD) Announced by Holzer &amp; Holzer, LLC"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ATLANTA, March  25, 2025  (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC is investigating whether CorMedix Inc. (\u201cCorMedix\u201d or the \u201cCompany\u201d) (NASDAQ: CRMD) complied with federal securities laws.\u00a0On March 25, 2025, Cormedix reported fourth quarter and full year 2024 financial results. During the Company\u2019s earnings call held the same day, Cormedix noted that \u201cwe do expect to begin to see some net price erosion beginning in the second quarter of 2025.\u201d Following this news, the price of the Company\u2019s stock dropped.\u00a0<\/p>\n<p align=\"justify\">If you purchased CorMedix stock and suffered\u202fa\u202floss on that investment, you are encouraged to contact Corey Holzer, Esq. at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=q-Kqx21b-jW8yV2xysx8URo-Xu_wp7M-puaUH6sn2YsRgHtwQAyysoCpsXkthtkr6wpvmqztu2OBGpD129Coo4o3P0KtczqUjeSZxlljDTg=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a> or Joshua Karr, Esq. at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SO3dqI8nAjcxLMVcB-Z7LNNP_pLXDPJIT3PTX3IUS3VoEHyfgfRkPYsFYyBVAh7gWNNCD35s1FGmMAv9zjLhLiuxBUxON9GjspUiGz2Oq3M=\" rel=\"nofollow\" target=\"_blank\">jkarr@holzerlaw.com<\/a>, call our toll-free number at (888) 508-6832, or visit our website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hEFoX9JHeTY2_UrnZmuS3ZpbrVY0TYZ6rsc0VvlO7tMMJjIUXTob8sDGTBibeuTqES87hOYUEnL8eVkaKfis-wM4gVaWVatbSI077iA33RDgjEeggc-0KYvtH3djycMBBT5qkhWU5sf9AfPlhy-Nbw==\" rel=\"nofollow\" target=\"_blank\">www.holzerlaw.com\/case\/cormedix\/<\/a> to discuss your legal rights.<\/p>\n<p align=\"justify\">Holzer &amp; Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, and 2023, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer &amp; Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct.\u202fMore information about the firm is available through its website, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hEFoX9JHeTY2_UrnZmuS3YmOFcaOl6KZHNqpu6zIStHxrhopiBlfjQPBVZ8y7P06Rqbay5VNDLzBI0YO9JhM0U6bHj9lkRBSIKGsmJwd3VM=\" rel=\"nofollow\" target=\"_blank\">www.holzerlaw.com<\/a>,\u202fand upon request from the firm. Holzer &amp; Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.\u202f\u00a0<\/p>\n<p align=\"justify\">CONTACT:\u202f\u00a0<br \/>Corey Holzer, Esq.<br \/>(888) 508-6832 (toll-free) <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=q-Kqx21b-jW8yV2xysx8URo-Xu_wp7M-puaUH6sn2Ys0UTxig-qWt2g2GMJy4wNDemDGACkiQ4_zoulVsita9e7TZdpWOjaPrBy5DJ6CUTg=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxMDg2NCM2ODM0MzE0IzIxODA3Njc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MDY3Y2M4N2EtNWRlYy00ZTMzLWE3MDctOTg3NzQwZWQ0NGEwLTExOTIzMzYtMjAyNS0wMy0yNS1lbg==\/tiny\/Holzer-Holzer.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ATLANTA, March 25, 2025 (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC is investigating whether CorMedix Inc. (\u201cCorMedix\u201d or the \u201cCompany\u201d) (NASDAQ: CRMD) complied with federal securities laws.\u00a0On March 25, 2025, Cormedix reported fourth quarter and full year 2024 financial results. During the Company\u2019s earnings call held the same day, Cormedix noted that \u201cwe do expect to begin to see some net price erosion beginning in the second quarter of 2025.\u201d Following this news, the price of the Company\u2019s stock dropped.\u00a0 If you purchased CorMedix stock and suffered\u202fa\u202floss on that investment, you are encouraged to contact Corey Holzer, Esq. at cholzer@holzerlaw.com or Joshua Karr, Esq. at\u00a0jkarr@holzerlaw.com, call our toll-free number at (888) 508-6832, or visit our website at www.holzerlaw.com\/case\/cormedix\/ to discuss &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;INVESTOR ALERT: Investigation of CorMedix Inc. (CRMD) Announced by Holzer &amp; Holzer, LLC&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-829739","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>INVESTOR ALERT: Investigation of CorMedix Inc. (CRMD) Announced by Holzer &amp; Holzer, LLC - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"INVESTOR ALERT: Investigation of CorMedix Inc. (CRMD) Announced by Holzer &amp; Holzer, LLC - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ATLANTA, March 25, 2025 (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC is investigating whether CorMedix Inc. (\u201cCorMedix\u201d or the \u201cCompany\u201d) (NASDAQ: CRMD) complied with federal securities laws.\u00a0On March 25, 2025, Cormedix reported fourth quarter and full year 2024 financial results. During the Company\u2019s earnings call held the same day, Cormedix noted that \u201cwe do expect to begin to see some net price erosion beginning in the second quarter of 2025.\u201d Following this news, the price of the Company\u2019s stock dropped.\u00a0 If you purchased CorMedix stock and suffered\u202fa\u202floss on that investment, you are encouraged to contact Corey Holzer, Esq. at cholzer@holzerlaw.com or Joshua Karr, Esq. at\u00a0jkarr@holzerlaw.com, call our toll-free number at (888) 508-6832, or visit our website at www.holzerlaw.com\/case\/cormedix\/ to discuss &hellip; Continue reading &quot;INVESTOR ALERT: Investigation of CorMedix Inc. (CRMD) Announced by Holzer &amp; Holzer, LLC&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-25T21:09:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxMDg2NCM2ODM0MzE0IzIxODA3Njc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"INVESTOR ALERT: Investigation of CorMedix Inc. (CRMD) Announced by Holzer &amp; Holzer, LLC\",\"datePublished\":\"2025-03-25T21:09:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\\\/\"},\"wordCount\":256,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxMDg2NCM2ODM0MzE0IzIxODA3Njc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\\\/\",\"name\":\"INVESTOR ALERT: Investigation of CorMedix Inc. (CRMD) Announced by Holzer &amp; Holzer, LLC - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxMDg2NCM2ODM0MzE0IzIxODA3Njc=\",\"datePublished\":\"2025-03-25T21:09:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxMDg2NCM2ODM0MzE0IzIxODA3Njc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQxMDg2NCM2ODM0MzE0IzIxODA3Njc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"INVESTOR ALERT: Investigation of CorMedix Inc. (CRMD) Announced by Holzer &amp; Holzer, LLC\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"INVESTOR ALERT: Investigation of CorMedix Inc. (CRMD) Announced by Holzer &amp; Holzer, LLC - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\/","og_locale":"en_US","og_type":"article","og_title":"INVESTOR ALERT: Investigation of CorMedix Inc. (CRMD) Announced by Holzer &amp; Holzer, LLC - Market Newsdesk","og_description":"ATLANTA, March 25, 2025 (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC is investigating whether CorMedix Inc. (\u201cCorMedix\u201d or the \u201cCompany\u201d) (NASDAQ: CRMD) complied with federal securities laws.\u00a0On March 25, 2025, Cormedix reported fourth quarter and full year 2024 financial results. During the Company\u2019s earnings call held the same day, Cormedix noted that \u201cwe do expect to begin to see some net price erosion beginning in the second quarter of 2025.\u201d Following this news, the price of the Company\u2019s stock dropped.\u00a0 If you purchased CorMedix stock and suffered\u202fa\u202floss on that investment, you are encouraged to contact Corey Holzer, Esq. at cholzer@holzerlaw.com or Joshua Karr, Esq. at\u00a0jkarr@holzerlaw.com, call our toll-free number at (888) 508-6832, or visit our website at www.holzerlaw.com\/case\/cormedix\/ to discuss &hellip; Continue reading \"INVESTOR ALERT: Investigation of CorMedix Inc. (CRMD) Announced by Holzer &amp; Holzer, LLC\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-25T21:09:25+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxMDg2NCM2ODM0MzE0IzIxODA3Njc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"INVESTOR ALERT: Investigation of CorMedix Inc. (CRMD) Announced by Holzer &amp; Holzer, LLC","datePublished":"2025-03-25T21:09:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\/"},"wordCount":256,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxMDg2NCM2ODM0MzE0IzIxODA3Njc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\/","name":"INVESTOR ALERT: Investigation of CorMedix Inc. (CRMD) Announced by Holzer &amp; Holzer, LLC - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxMDg2NCM2ODM0MzE0IzIxODA3Njc=","datePublished":"2025-03-25T21:09:25+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxMDg2NCM2ODM0MzE0IzIxODA3Njc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQxMDg2NCM2ODM0MzE0IzIxODA3Njc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-investigation-of-cormedix-inc-crmd-announced-by-holzer-holzer-llc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"INVESTOR ALERT: Investigation of CorMedix Inc. (CRMD) Announced by Holzer &amp; Holzer, LLC"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/829739","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=829739"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/829739\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=829739"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=829739"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=829739"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}